Meconium peritonitis is an intense, inflammatory reaction of the fetal peritoneum due to intrauterine bowel perforation. This condition can present in several ways: meconium ascites, meconium pseudocyst, and intra-abdominal calcium deposits. Any source of bowel obstruction may result in meconium peritonitis, such as small-bowel atresia, volvulus, intussusception, Meckel's diverticulum, congenital bands, vascular insufficiency, and meconium ileus due to cystic fibrosis. 1, 2 Because meconium ileus secondary to cystic fibrosis can account for 25% to 40% of meconium peritonitis cases, cystic fibrosis must be a strong consideration. 3, 4 Cystic fibrosis is the most common lethal genetic disorder among Caucasians, involving the dysfunction of all exocrine glands. 5 Both meconium peritonitis and cystic fibrosis are life-threatening conditions. Accurate prenatal ultrasound diagnosis of meconium peritonitis and subsequent testing for cystic fibrosis can aid in establishing an appropriate surgical and therapeutic management plan.
Case Presentation
A 36-year-old woman was referred for a sonographic evaluation of a 29-week pregnancy, presenting in size as smaller than gestational age. An obstetrical sonogram was performed with a Diasonics SPA 1000 using a 3.5-MHz curved linear array transducer. Scanning revealed a single fetus in breech position. Fetal measurements indicated a gestational age of approximately 24 weeks. The placenta was posterior and normal in appearance. There was a normal amount of amniotic fluid. Fetal heart motion and fetal activity were observed. No fetal abnormalities were seen except for a small amount of ascites noted within the fetal abdomen (see Fig. 1 ). A follow-up examination was suggested to ascertain the significance of the ascites. At 34 weeks gestational age, a repeat sonogram was performed. The sonogram was performed with a Diasonics Gateway using a 4.0-MHz curved linear array transducer. The fetus was in vertex position, the placenta was posterior and mature in appearance, and a normal amount of amniotic fluid was present. Fetal heart motion and fetal activity were normal. Fetal ascites was no longer apparent. Newly noted were several clusters of calcifications along the anterior peritoneal wall (see Figs. 2, 3, 4) . Meconium peritonitis was included in the differential diagnosis, and the suggestion was made to test for cystic fibrosis. After a full-term delivery, an abdominal x-ray was performed. The film revealed scattered intraabdominal calcifications, consistent with intrauterine meconium peritonitis. The bowel pattern appeared within normal limits, without continuing evidence of bowel perforation (see Fig. 5 ). Two weeks later, a sweat test was performed on the infant. Results were consistent with a diagnosis of cystic fibrosis.
Discussion
Meconium peritonitis is a rare condition, with an incidence of 1 in 30,000 live births. This condition manifests as a peritoneal inflammatory reaction to intrauterine bowel perforation associated with bowel obstruction from small-bowel atresia, volvulus, intussusception, Meckel's diverticulum, congenital bands, vascular insufficiency, or meconium ileus due to cystic fibrosis. 1,2 After bowel perforation, the leakage of meconium and digestive enzymes into the peritoneal cavity can present sonographically as ascites, followed by one of two inflammatory manifestations: fibroadhesive or cystic. The fibroadhesive type is characterized by an intense inflammatory reaction of the peritoneum, leading to formation of calcium deposits, some of which seal off the perforation. A pseudocyst formed by the fixation of the bowel loops surrounding the site of ongoing leakage characterizes the cystic type. Inflammation often calcifies the pseudocyst wall. Because fetal meconium is sterile, intrauterine bowel perforation does not lead to bacterial contamination. 4 In this study, ultrasound identified the initial meconium ascites, followed by the scattered intra-abdominal calcifications of fibroadhesive peritonitis.
Cystic fibrosis is an autosomal recessive disorder with an incidence of 1 in 2000 live births and a survival rate of 50% into the mid 20s. With no known cure, it is the most common lethal genetic disorder affecting Caucasians. Abnormally thick mucous secretions adversely affect the lungs and gastrointestinal system.
Gastrointestinal complications are common and often occur in utero. Meconium ileus occurs in 10% to 15% of cases of cystic fibrosis. 5, 6 The characteristic appearance of meconium peritonitis secondary to meconium ileus and subsequent bowel perforation can be identified with ultrasound. Differential diagnosis must include other causes of ascites and intra-abdominal calcification, such as cytomegalovirus or toxoplasmosis. The meconium pseudocyst must be differentiated from other intra-abdominal cysts or masses, including ovarian, urachal, mesenteric, hematometrocolpos, hematoma, and neoplasm. 1 Prenatal evaluation should include the testing of maternal blood for Rh-sensitive antibodies, cytomegalovirus, and toxoplasmosis. DNA testing can confirm cystic fibrosis in utero in a majority of cases. The most common gene mutation for this disorder accounts for 70% of cases of cystic fibrosis; more than 50 other gene mutations account for the remainder of cases. 1, 6 Formerly, the prognosis for newborns with meconium peritonitis was very poor: literature in 1984 reported an abysmal 62% mortality rate in the neonate period. 4 Currently, due to advances in surgical care and postoperative management, most newborns with this condition do well. Serial ultrasound scanning can demonstrate the ongoing status and type of meconium peritonitis. Some cases may improve and even resolve in utero. The perforated bowel may seal in utero or during the neonate period. If meconium leakage continues in utero, and ascites rapidly progresses, intervention by fetal paracentesis and/or induction of labor and delivery may be necessary. Continued leakage in the neonate period is an indication for surgical repair. Recent literature indicates a survival rate of nearly 100% for newborns with meconium peritonitis. 3
46
JOURNAL 
